Strategic Partners RPRD Diagnostics is a precision medicine-focused PGx lab that already collaborates with pediatric cancer centers and has a track record in supporting clinical decision-making. Potential sales opportunity: approach leading pediatric oncology networks and hospital systems to expand pharmacogenomics panels and bundled PGx services for broader patient cohorts.

Clinical Utility Tests like comprehensive PGx and targeted CNT Panel for thiopurine toxicity demonstrate clear patient care value and cost-saving potential. Potential sales opportunity: tailor solutions for healthcare providers and pharma partners emphasizing improved outcomes and pharmacoeconomic benefits.

Market Position Small, specialized lab with niche capabilities and recognition as a PGx reference lab for top pediatric centers suggests a high-value, low-volume model. Potential sales opportunity: target mid-to-large pediatric oncology programs and niche pharma collaborations seeking precision dosing and safety profiling.

Expansion & Outreach Recent collaboration with Children’s Minnesota indicates openness to joint implementations of pharmacogenomic testing processes. Potential sales opportunity: propose multi-site deployment strategies and co-marketing opportunities with hospital systems and patient advocacy groups.

Growth Readiness Revenue range indicates a growing, revenue-generating business with potential scale through partnerships and expanded service lines. Potential sales opportunity: offer strategic account management, scalable lab services, and integration with hospital LIS/EMR workflows to attract larger healthcare and pharmaceutical clients.